COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 1625: Articles 16241-16250  | Next

Quantifying Face Mask Comfort
Koh, E., Ambatipudi, M., Boone, D. L., Luehr, J. B. W., Blaise, A., Gonzalez, J., Sule, N., Mooney, D. J., He, E. M.
10.1101/2021.03.31.21254723 — Posted: 2021-04-06
Efficient Maternal to Neonatal transfer of SARS-CoV-2 and BNT162b2 antibodies
Beharier, O., Plitman Mayo, R., Raz, T., Nahum Sacks, K., Schreiber, L., Suissa-Cohen, Y., Chen, R., Gomez-Tolub, R., Hadar, E., Gabbay-Benziv, R., Jaffe Moshkovich, Y., Biron-Shental, T., Shechter-Maor, G., Farladansky-Gershnabel, S., Yitzhak Sela, H., Benyamini-Raischer, H., Sela, N. D., Goldman-Wohl, D., Shulman, Z., Many, A., Barr, H., Yagel, S., Neeman, M., Kovo, M.
10.1101/2021.03.31.21254674 — Posted: 2021-04-06
Humoral response to Pfizer mRNA vaccine against SARS CoV2, in patients with autoimmune inflammatory rheumatic diseases and the impact on the rheumatic disease activity
Braun-Moscovici, Y., Kaplan, M., Markovits, D., Giryes, S., Toledano, K., Tavor, Y., Dolnikov, K., Balbir-Gurman, A.
10.1101/2021.04.02.21254493 — Posted: 2021-04-06
High SARS-CoV-2 attack rates following exposure during singing events in the Netherlands, September-October 2020
Shah, A. A., Dusseldorp, F., Veldhuijzen, I. K., te Wierik, M. J. M., Bartels, A., Schijven, J., Vermeulen, L. C., Knol, M. J.
10.1101/2021.03.30.21253126 — Posted: 2021-04-06
Genomic epidemiology of SARS-CoV-2 in Russia reveals recurring cross-border transmission throughout 2020
Matsvay, A., Klink, G. V., Safina, K. R., Nabieva, E., Garushyants, S. K., Biba, D., Bazykin, G. A., Mikhaylov, I. M., Say, A. V., Zakamornaya, A. I., Khakhina, A. O., Lisitsa, T. S., Ayginin, A. A., Abramov, I. S., Bogdan, S. A., Kolbutova, K. B., Oleynikova, D. U., Avdeenko, T. F., Shipulin, G. A., Yudin, S. M., Skvortsova, V. I.
10.1101/2021.03.31.21254115 — Posted: 2021-04-06
Timing is everything: the relationship between COVID outcomes and the date at which mask mandates are relaxed
Shoukat, A., Galvani, A. P., Fitzpatrick, M. C.
10.1101/2021.03.31.21254646 — Posted: 2021-04-06
Statins Are Associated with Improved 28-day Mortality in Patients Hospitalized with SARS-CoV-2 Infection
Memel, Z. N., Lee, J. J., Foulkes, A. S., Chung, R. T., Thaweethai, T., Bloom, P. P.
10.1101/2021.03.27.21254373 — Posted: 2021-04-06
Therapeutic application of alpha-1-antitrypsin in COVID-19
Ritzmann, F., Chitirala, P., Yao, Y., Krueger, N., Hoffmann, M., Zuo, W., Lammert, F., Smola, S., Seiwert, N., Tov, N., Alagem, N., Mozafari, B., Guenther, K., Seibert, M., Hoersch, S., Volk, T., Lepper, P. M., Danziger, G., Poehlmann, S., Beisswenger, C., Herr, C., Bals, R.
10.1101/2021.04.02.21252580 — Posted: 2021-04-06
Increasing concentration of COVID-19 by socioeconomic determinants and geography in Toronto, Canada: an observational study
Mishra, S., Ma, H., Moloney, G., Yiu, K. C., Darvin, D., Landsman, D., Kwong, J., Calzavara, A., Straus, S., Chan, A. K., Gournis, E., Rilkoff, H., Xia, Y., Katz, A., Williamson, T., Malikov, K., Kustra, R., Maheu-Giroux, M., Sander, B., Baral, S.
10.1101/2021.04.01.21254585 — Posted: 2021-04-06
Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests
Kanji, J. N., Bailey, A., Fenton, J., Ling, S. H., Rivera, R., Plitt, S., Sligl, W. I., Taylor, S. C., Turnbull, L., Tipples, G., Charlton, C. L.
10.1101/2021.03.30.21254604 — Posted: 2021-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).